BLOOMINGTON, Ind.--(HSMN NewsFeed)--Cook Pharmica, the contract biopharmaceutical manufacturing and development services division of Cook Medical, announced today that it has signed an agreement with Inspiration Biopharmaceuticals, to conduct development work for its lead biologic therapy, an intravenous Factor IX product for patients with hemophilia B. Activities will be performed in Cook Pharmica’s development laboratory within its Bloomington, Ind. facility.
Full text >>
Monday, November 19, 2007
Cook Pharmica Signs Agreement with Inspiration Biopharmaceuticals for the Transfer of its Clinical Manufacturing Process for Lead Hemophilia Compound
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment